- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ACA Insurance Premiums Set to Spike in Some States
Fears of health insurance premium hikes during the third year of the Affordable Care Act may not be unfounded. In Tennessee, the state's insurance commissioner just approved BlueCross BlueShield of Tennessee's 36.3% increase.
Fears of health insurance premium hikes during the third year of the Affordable Care Act may not be unfounded. In Tennessee, the state’s insurance commissioner just approved BlueCross BlueShield of Tennessee's 36.3% increase.
According to the Wall Street Journal, several regulators around the country agree with her. Many have already approved big premium increases sought by the largest health plans in their states. Not all states have made their rate decisions yet and some—such as California, which announced increases of just 4%—have approved only modest increases. However, some of the states with lower average premium increases already had high rates to begin with. Tennessee had some of the lowest premiums in the country initially.
In Oregon, Moda Health Plan received approval to increase rates by 25.6%; Health Cooperative in Kentucky was approved to increase rates by 25.1%; and Blue Cross of Idaho Health Service has been approved to increase rates by 23%, on average.
Read the full article from Wall Street Journal: http://on.wsj.com/1EXJwdV
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
